Seers KRX:458870KOSDAQ
씨어스테크놀로지 · Korean news coverage and regulatory filings, organized.
Articles, 24h3
Articles, 7 days16
DART filings, 7 days1
Articles tracked16since Sep 11
In Q2 2026, Seers reported revenue of ₩28.4bn, up 256.7% year on year, and operating profit of ₩12.9bn. Seers (씨어스테크놀로지) appeared in 16 Korean news articles and 1 DART filing over the past seven days. Coverage peaked on Sep 14 with 14 articles. The most common catalyst was clinical & approvals (1). It was most often mentioned alongside Sky Labs and Jlk.
Seers quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩28.4bn | +256.7% | ₩12.9bn | ₩12.9bn |
| Q1 2026 | ₩32.5bn | +699.6% | ₩13.9bn | ₩13.7bn |
| Q4 2025 derived | ₩20.4bn | +272.1% | ₩8.7bn | ₩8.4bn |
| Q3 2025 | ₩15.7bn | +1499.1% | ₩6.7bn | ₩6.7bn |
| Q2 2025 | ₩8.0bn | +799.5% | ₩1.5bn | ₩1.5bn |
| Q1 2025 | ₩4.1bn | +445.1% | −₩588m | −₩593m |
| Q4 2024 derived | ₩5.5bn | +523.1% | ₩328m | ₩281m |
| Q3 2024 | ₩984m | +162.3% | −₩3.5bn | −₩3.5bn |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.
Seers top stories 2 weeks, by number of outlets
- 1
- 2
- 3
- 4
- 5
- 6
Latest Seers news Korean headlines
-
씨어스, 두바이 EVIDENT Summit 참가…모비케어·씽크 선보여
2 more on this story · 2 outlets
- [BioS]씨어스, 두바이 ‘EVIDENT Summit 2026’ 참가이투데이 · Sep 14 11:15
- 씨어스, 두바이 ‘EVIDENT Summit 2026’ 참가뉴스타운 · Sep 14 13:29
-
씨어스, 두바이 '에비던트 써밋' 참가…"중동 의료시장 공략"
4 more on this story · 3 outlets
- 씨어스, ‘에비던트 써밋’ 참가…중동 시장 공략 가속이데일리 · Sep 14 10:02
- 씨어스, ‘에비던트 써밋’ 참가…중동 시장 공략 가속이데일리 · Sep 14 10:02
- 씨어스, 두바이 심혈관 학술행사 참가…중동 의료시장 공략뉴스1 · Sep 14 10:18
- 씨어스, 두바이 ‘에비던트 써밋’ 참가…중동 심혈관 의료시장 공략더바이오 · Sep 14 11:15
